bioRxiv Science⌕ Search

bioRxiv · 10.1101/2020.06.21.163485

LATER but FORTIOR: diffusion modelling of inhibition of return

Abstract

Inhibition of return (IOR) refers to the slowing of response times (RTs) for stimuli repeated at previously inspected locations, as compared with novel ones. However, the exact processing stage(s) at which IOR occurs, and its nature across different response modalities, remain debated. We tested predictions on these issues originating from the FORTIOR model (fronto-parietal organization of response times in IOR; Seidel Malkinson & Bartolomeo, 2018), and from evidence accumulation models. We reanalysed RT data from a target-target IOR paradigm (Bourgeois et al.,2013a, 2013b) by using a LATER-like evidence accumulation model (Carpenter & Williams, 1995), to test the predictions of FORTIOR, and specifically whether IOR could occur at sensory/attentional stages of processing, or at stages of decision and action selection. We considered the following conditions: manual or saccadic response modality, before or after TMS perturbation over four cortical regions. Results showed that the Gaussian noise parameter best explained both manual and saccadic IOR, suggesting that in both response modalities IOR may result from slower accumulation of evidence for repeated locations. Additionally, across stimulated regions, TMS affected only manual RTs, lowering them equally in the conditions with repeated targets (Return) and non-repeated targets (Non-return). Accordingly, the modelling results show that TMS stimulation did not significantly alter the pattern between model parameters, with the Gaussian noise parameter remaining the parameter best explaining the Return - Non-return RT difference. Moreover, TMS over the right intra-parietal sulcus (IPS) perturbed IOR by shortening the Return RT. When directly testing this effect by modelling the TMS impact in the Return condition, the Bayesian information criterion of the Gaussian noise parameter was the smallest, but this effect did not reach significance. These results support the hypothesis that target-target IOR is a predominantly sensory/attentional phenomenon, and may be modulated by activity in fronto-parietal networks.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Seidel Malkinson, T., Bourgeois, A., Wattiez, N., Pouget, P., Bartolomeo, P.. 2020-06-22. LATER but FORTIOR: diffusion modelling of inhibition of return. https://doi.org/10.1101/2020.06.21.163485

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epidermal Langerhans Cells Act as Neuroimmune Regulators of Pain and Itch

Neuroimmune interactions in the skin coordinate immune defense and somatosensory perception, yet how immune cells shape sensory signaling remains poorly defined. Here, we show that Langerhans cells (LCs), epidermal antigen-presenting cells, function as local immune-derived amplifiers of cutaneous sensory signaling. Anatomical and transcriptomic analyses reveal preferential LC association with non-peptidergic sensory neurons. LC activation increases neuronal and behavioral responses to thermal, mechanical, and pruritic stimuli without directly exciting sensory neurons, whereas LC inhibition or ablation selectively reduces pruritogen-evoked itch. We identified semaphorin 7A as a candidate LC-expressed mediator. Semaphorin 7A sensitized cultured sensory neurons to chloroquine and histamine, and neutralizing semaphorin 7A abolished the increase in chloroquine-evoked scratching produced by LC activation. Its receptor PlexinC1 was expressed by most MrgprA3 pruriceptors and blocking PlexinC1 reduced semaphorin 7A-evoked neuronal responses. Together, these findings identify epidermal LCs as local immune-derived amplifiers that regulate the responsiveness of cutaneous sensory circuits and identify semaphorin 7A as a mediator of LC-induced itch potentiation.

neuroscience↗

Feasible closed-loop stimulation for neural latent dynamics control

Modern neuroscience benefits from powerful computational and experimental methods for studying neural populations, including latent dynamics models that predict behavior with few dimensions. But despite their explanatory utility, latent factors are seldom targeted explicitly with experimental perturbations, leaving causal relationships to behavior and inferred dynamical landscapes untested. A promising solution is closed-loop, multi-channel optogenetic control, which, when paired with model predictions, could steer neural trajectories in real time--a feat impossible for traditional, hand-designed stimulation. However, because closed-loop latent control has not been demonstrated in vivo, the hardware and software requirements remain unclear--particularly the necessary stimulation dimensionality and how limited resources such as implant volume and bandwidth should be allocated between stimulation and recording capabilities. Preliminary experiments would thus help guide ongoing technological development. As large-scale exploration of these design spaces in vivo is prohibitively expensive, we conducted a high-throughput simulation survey using biophysically grounded spiking neural networks. We found that low-dimensional actuation is sufficient: in the reference configuration, ~20% of the stimulation channels achieved ~85% of peak control performance, far fewer than the number of neurons. Furthermore, allocating channels roughly equally between stimulation and recording optimized behavioral control, whereas pairing many electrodes with a single light source--the prevailing practice in experimental labs--performed poorly. Even without heavily optimizing modeling or control, we obtained >60% tracking error reduction and >90% evoked behavior accuracy on average for optimal channel counts. These results held across extensive parameter variations, suggesting that closed-loop latent control is feasible with accessible channel counts and establishing design principles for future tool development and in vivo experiments.

neuroscience↗

Identification of Kinome Biomarkers and Therapeutic Rescue in cGMP-Linked Retinal Degeneration

Inherited retinal degenerations, such as Retinitis Pigmentosa (RP) and Leber's congenital amaurosis (LCA), are major causes of progressive and irreversible vision loss. The large number of genes associated with these disorders makes their clinical and molecular characterization difficult, while systemic biomarkers for disease progression or treatment response remain limited. These challenges were addressed by targeting cGMP-associated mechanisms shared by RP and LCA and integrating systemic biomarker profiling with retinal outcomes. Kinase activity analysis (kinome analysis) in peripheral blood mononuclear cells distinguished healthy and diseased states and captured therapy-associated signatures in rd10 mice treated with LP-CN03, a liposomal formulation of the cGMP analog CN03. This first systemic analysis in a therapeutically responsive animal model highlights kinome analysis as a potential translational readout. Given shared cGMP signaling in RP and AIPL1-associated LCA, LP-CN03's therapeutic potential was further evaluated in a new CRISPR-Cas9-generated Aipl1-/- mouse model. Treatment with LP-CN03 preserved retinal structure and function, as shown by electroretinography, longitudinal optical coherence tomography, fundus imaging, optomotor testing, and photoreceptor-specific gene expression. Together, these findings provide independent in vivo evidence for the neuroprotective effect of LP-CN03 in both cGMP-related RP and LCA, also highlighting the translational value of kinome profiling.

neuroscience↗